Vertex Pharmaceuticals Incorporated (LON:0QZU)
421.74
+0.41 (0.10%)
At close: Nov 20, 2025
Vertex Pharmaceuticals Employees
Vertex Pharmaceuticals had 6,100 employees as of December 31, 2024. The number of employees increased by 700 or 12.96% compared to the previous year.
Employees
6,100
Change (1Y)
700
Growth (1Y)
12.96%
Revenue / Employee
1.43M GBP
Profits / Employee
448.21K GBP
Market Cap
82.73B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6,100 | 700 | 12.96% |
| Dec 31, 2023 | 5,400 | 600 | 12.50% |
| Dec 31, 2022 | 4,800 | 900 | 23.08% |
| Dec 31, 2021 | 3,900 | 500 | 14.71% |
| Dec 31, 2020 | 3,400 | 400 | 13.33% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,349 |
| Spire Healthcare Group | 15,703 |
| ConvaTec Group | 10,489 |
| Hikma Pharmaceuticals | 9,500 |
| Genus | 3,190 |
Vertex Pharmaceuticals News
- 18 hours ago - Noteworthy ETF Outflows: IWF, VRTX, BX, MCK - Nasdaq
- 2 days ago - Insider Sell: Atkinson Edward Morrow III Sells Shares of Vertex Pharmaceuticals Inc (VRTX) - GuruFocus
- 2 days ago - Vertex to Participate in the Citi's 2025 Global Healthcare Conference on December 3 - Business Wire
- 3 days ago - Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know - Nasdaq
- 3 days ago - Columbia Contrarian Core Fund Q3 2025 Performance Review - Seeking Alpha
- 4 days ago - 3 Best Healthcare Stocks: Quant Strong Buys From Goldman's 'Alpha' List - Seeking Alpha
- 4 days ago - Is Vertex Pharmaceuticals Inc Gaining or Losing Market Support? - Benzinga
- 5 days ago - PGIM Jennison Health Sciences Fund Q3 2025 Contributors And Detractors - Seeking Alpha